The nation of Zimbabwe has declined a significant American healthcare agreement worth $367m (272 million pounds) over five years due to Washington's insistence on confidential biological samples.
This rejection was revealed after a government memo from December was leaked, revealing that President Emmerson Mnangagwa felt the agreement was "skewed".
An official representative later stated that the United States was requesting biological samples for research and commercial gain while was unwilling to guarantee the resulting advantages from future vaccines.
"We will now turn to the difficult and regrettable process of winding down our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had provided more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has appealed for continued negotiations to secure a deal acceptable to all parties so the nation's critical HIV programme can be sustained.
Wider Background
This development comes after a similar case in Kenya, where a court halted a similar health funding agreement after legal challenges were raised about the security of citizens' medical information.
Since resuming office recently, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
USAID had overseen aid for the US government, but Trump claimed its spending was "inefficient" and his administration was seeking direct bilateral deals to enhance transparency and responsibility.
As per reports, 16 nations in Africa have to date agreed to similar health pacts, constituting over $18.3bn in new funding.
Specifics of the Rejected Deal
The funds for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation would have delivered significant advantages for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy via American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana said the arrangement was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data for a long time, with no corresponding promise of access to any medical innovations – such as new medicines or tests – that could be developed from that provided information," his statement read.
"Effectively, our country would provide the basic resources for medical research without any certainty that the end products would be accessible to our citizens if a future health crisis arise."
National Interest and Global Health
He also noted that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were disrupting systems previously established through the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to deal with potential global health emergencies.
"This system is designed to guarantee that when a country contributes its data, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to create them."
These objections over the US deal "are not meant as opposition to America," Mangwana stressed.
"We are open to continued dialogue with our American counterparts on how future collaboration could be structured in a manner that respects the sovereignty and dignity of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but urged that negotiations should continue given that a large portion of the nation's HIV programmes depended on foreign aid.
"In cases where technical issues exist, including those involving information security or agreement terms, these can frequently be resolved via detailed discussion and negotiated safeguards," the group commented.
This impasse highlights the complex challenges between accepting much-needed foreign assistance and safeguarding national sovereignty in an ever more interconnected world.